BRIEF-Newron Pharmaceuticals: Zambon Announces Approval And ARTG Listing Of Safinamide In Australia
1 分钟阅读
Nov 30 (Reuters) - Newron Pharmaceuticals SpA:
* ZAMBON ANNOUNCES APPROVAL AND ARTG LISTING OF SAFINAMIDE IN AUSTRALIA FOR TREATMENT OF PATIENTS WITH PARKINSON'S DISEASE Source text for Eikon: Further company coverage: (Gdynia Newsroom)